Anxiety
Articles about Anxiety
6 Psychiatry Headlines You Missed in January 2026
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure ...
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) --
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the ...
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vistagen (VTGN) To Contact Him Directly To Discuss Their Options
Guideline-based treatment linked to better outcomes for kids with anxiety and depression
A new Yale study finds that adolescents with anxiety or depression fair better when doctors follow FDA approvals or professional treatment guidelines rather than freelancing off-label treatments.
From Croatia to MAHA: How an unapproved drug became the next hot peptide
BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.
Addex Announces Publication Of Preclinical Data Supporting Potential Of Mglu7 Negative Allosteric Modulators To Transform Anxiety And Fear-Related Disorder Treatment
(MENAFN - GlobeNewsWire - Nasdaq) Data published in Molecular Psychiatry Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, February 3, 2026 - Addex Therapeutics (SIX: ADXN ...
Global Sleep Disorder Market Report 2026 Business Expansion, Key Growth Drivers, And Trends Through 2030
(MENAFN - EIN Presswire) EINPresswire/ -- Understanding the growing importance of sleep health reveals why the sleep disorder market is expanding so rapidly. With an increasing number of people ...
A Guide to Proven Anxiety Treatment Options for 2025
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Vistagen Therapeutics, Inc. Investors to Secure ...
NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) --
Incannex Healthcare Announces Formation Of Clinical Advisory Board For PSX-001 Program
(MENAFN - GlobeNewsWire - Nasdaq) Strengthens clinical and regulatory guidance as PSX-001 advances to its next phase of developmentMELBOURNE, Australia and NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) ...